Advances in the diagnosis and treatment of gallbladder carcinoma
10.3969/j.issn.1001-5256.2023.11.032
- VernacularTitle:胆囊癌的诊断与治疗进展
- Author:
Yi LE
1
;
Hao YANG
1
;
Hu LIU
1
;
Zhaoyang CUI
1
;
Xiangning ZHAO
1
;
Liang AN
1
;
Haizhu LI
1
;
Shaogeng ZHANG
1
Author Information
1. Department of Tumor Surgery， Shanghai Mengchao Cancer Hospital， Shanghai 201805， China
- Publication Type:Review
- Keywords:
Gallbladder Neoplasms;
Risk Factors;
Diagnosis;
Therapeutics
- From:
Journal of Clinical Hepatology
2023;39(11):2738-2744
- CountryChina
- Language:Chinese
-
Abstract:
Gallbladder carcinoma is a common malignant tumor of the biliary system characterized by poor specificity of early symptoms， a high degree of malignancy， and rapid progression， and it is difficult to make an early diagnosis. Gallstones and gallbladder polyps are considered the most common risk factors for gallbladder carcinoma. Ultrasound is the preferred examination， while CT， MRI， and PET also have their own advantages. There is a lack of radical treatment methods for gallbladder carcinoma， and surgical operation remains the preferred treatment method for gallbladder carcinoma； however， due to the rapid progression of this disease， most patients have lost the opportunity for surgery at the time of diagnosis. A combination of various treatment modalities， such as radiochemotherapy， targeted therapy， and immunotherapy， has improved the prognosis of patients to a certain extent， but with an unsatisfactory long-term therapeutic effect. Therefore， it is of particular importance to give priority to prevention rather than treatment and emphasize early identification and treatment.
